US man charged with killing his four children, mother-in-law in shooting
Darpan News Desk IANS, 01 Dec, 2021 03:02 PM
Los Angeles, Dec 1 (IANS) A man was charged with killing his four children and mother-in-law over the weekend inside a home in the western US state of California, authorities said.
Germarcus Lamar David, 29, faces five counts of murder and three counts of assault on a child causing death, said the Los Angeles County District Attorney's Office in a news release on Tuesday.
David is accused of fatally shooting the five victims aged 11, 7, 2, 1 and 51 at the family home on the 3,500 block of Garnet Lane in Lancaster in northern Los Angeles County, according to the news release.
"No family should endure this type of tragedy, especially when the alleged perpetrator was responsible for their protection," Xinhua news agency quoted the county's District Attorney George Gascon saying.
"Our office has reached out to the family to ensure they have all the services and support they need during this difficult time," Gascon added.
The incident was reported Sunday evening. David is being held in lieu of a 2-million-US-dollar bail and expected to appear in a court Tuesday.
The poll from The Associated Press-NORC Center for Public Affairs Research found only 46% of Americans want a COVID-19 vaccine and another 29% are unsure.
The COLA affects the personal finances of about 1 in 5 Americans, including Social Security recipients, disabled veterans and federal retirees, some 70 million people in all.
The Associated Press-NORC Center for Public Affairs Research poll finds that 17% of Americans say they are providing ongoing caregiving, part of an informal volunteer corps.
Reinfection so far has been rare. The best known example: Researchers in Hong Kong said a man had mild COVID-19 and then months later was infected again but showed no symptoms.
Antibodies are proteins the body makes when an infection occurs; they attach to a virus and help it be eliminated. Vaccines mimic an infection to spur antibody production.
Eli Lilly and Company announced the partial results Wednesday in a news release; they have not yet been published or reviewed by independent scientists.
